Long-term outcomes and morbidity after I125 brachytherapy for localised prostate cancer:: An early UK series

被引：3
|
作者：
Hellawell, GO [1 ]
Ho, K [1 ]
Halliwell, M [1 ]
Appleby, H [1 ]
Le Monnier, K [1 ]
Boiangiu, I [1 ]
Davies, DR [1 ]
Fellows, G [1 ]
Whipp, E [1 ]
Brewster, SF [1 ]
机构：
[1] Dept Urol, Oxford, England
来源：
CLINICAL ONCOLOGY | 2005年 / 17卷 / 01期
关键词：
D O I：
10.1016/j.clon.2004.09.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：68 / 69
页数：2
相关论文
共 50 条
  • [21] Is long-term urinary morbidity after prostate brachytherapy under-reported?
    Kaul, A.
    Singh, P.
    Smith, G.
    Pigott, K.
    Mishra, V.
    BJU INTERNATIONAL, 2015, 115 : 27 - 27
  • [22] Eight years experience of local prostate cancer treatment with permanent I125 seed brachytherapy - Morbidity and outcome results
    Aaltomaa, Sirpa H.
    Kataja, Vesa V.
    Lahtinen, Tapani
    Palmgren, Jan-Erik
    Forsell, Tapio
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 (02) : 213 - 216
  • [23] Report on the early efficacy and tolerability of I125 permanent prostate brachytherapy from a UK multi-institutional database
    Mitchell, D. M.
    Wylie, J. P.
    Mandall, P.
    Bottomley, D. M.
    Hoskin, P. J.
    BJU INTERNATIONAL, 2008, 101 : 5 - 5
  • [24] Report on the Early Efficacy and Tolerability of I125 Permanent Prostate Brachytherapy from a UK Multi-institutional Database
    Mitchell, D. M.
    Mandall, P.
    Bottomley, D.
    Hoskin, P. J.
    Logue, J. P.
    Ash, D.
    Ostler, P.
    Elliott, T.
    Henry, A.
    Wylie, J. P.
    CLINICAL ONCOLOGY, 2008, 20 (10) : 738 - 744
  • [25] Long-term outcomes of LDR-brachytherapy for localized prostate cancer
    Makela, Lauri
    Petas, Anssi
    Mikkola, Arto
    Visapaa, Harri
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [26] Association between long-term erectile dysfunction and biochemical recurrence after permanent seed I125 implant brachytherapy for prostate cancer. A longitudinal study of a single-institution
    Morgia, Giuseppe
    Castelli, Tommaso
    Privitera, Salvatore
    Al-Nakib, Chaled
    Favilla, Vincenzo
    Marchese, Francesco
    Cimino, Sebastiano
    Russo, Giorgio Ivan
    AGING MALE, 2016, 19 (01): : 15 - 19
  • [27] LOW DOSE BRACHYTHERAPY WITH I125 IN PATIENTS WITH LOCAL PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY.
    Gomez Veiga, F. G.
    Gomez, Marino A., I
    Castelo, L. A.
    Gonzalez, Dacal J.
    Lopez, D.
    Ponce, J.
    Candal, A.
    Chantada, V
    JOURNAL OF UROLOGY, 2010, 183 (04): : E232 - E232
  • [28] Predictive Factors for Urinary Morbidity after I-125 Prostate Brachytherapy
    Senzaki, T.
    Fukumori, T.
    Komori, M.
    Yamamoto, Y.
    Yamaguchi, K.
    Nakatsuji, H.
    Izaki, H.
    Takahashi, M.
    Kanayama, H.
    UROLOGY, 2012, 80 (03) : S292 - S292
  • [29] Long-term outcomes of a prospective randomized trial of 131Cs/125I permanent prostate brachytherapy
    Moran, Brian J.
    Koroulakis, Antony
    Decesaris, Cristina
    Braccioforte, Michelle H.
    Amin, Neha
    Agarwal, Manuj
    BRACHYTHERAPY, 2021, 20 (01) : 38 - 43
  • [30] Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 study
    Salem, N
    Simonian-Sauve, M
    Rosello, R
    Alzieu, C
    Gravis, G
    Maraninchi, D
    Bladou, F
    RADIOTHERAPY AND ONCOLOGY, 2003, 66 (02) : 159 - 165
12345